Cited in boardrooms, legal proceedings & government briefings since 2017

The Cannabis Testing Report offers comprehensive and invaluable insights into the critical aspect of cannabis testing.
Cited in boardrooms, legal proceedings & government briefings since 2017. Our figures are built to be defended — sourced, modelled and signed off by PP’s analysts.
Trusted by teams at
The Cannabis Testing Report offers comprehensive and invaluable insights into the critical aspect of cannabis testing. It combines PP’s proprietary market sizing with regulatory analysis, giving investors and corporates a single, citable reference — delivered digitally, licensed for internal use, and backed by the analysts who built the numbers.
delivery format
The global cannabis industry is undergoing rapid growth, attracting numerous new entrants seeking to establish a foothold in this evolving market. Due to the swift expansion of the sector, the practice and regulation around product testing and quality control, both in-house as part of manufacturing and third-party as part of independent quality checks, is still in the process of development. As the industry becomes more sophisticated, technological advancements and a growing wealth of knowledge around cannabis testing will allow comprehensive regulatory frameworks to be developed, and quality control systems to become harmonised internationally. Currently, due to the emerging nature of the industry, there are a variety of different approaches taken by regulators and operators in different markets regarding cannabis testing. Nevertheless, a focus on testing is increasingly being prioritised as the sector places greater emphasis on transparency and product quality. As the wider cannabis industry grows, so too does the market for cannabis testing. To understand the revenue potential of the global cannabis testing market, it is helpful to look at how much similar sectors, like the food & beverage sectors or pharmaceuticals, spend on testing. Based on this measure, the total global market size for cannabis testing could range from 0.29% to 0.64%, of the total global cannabis market size. In absolute terms, this means that by 2027, global cannabis testing could be worth between US$360 million and US$770 million. The growth and development of cannabis testing is a necessary prerequisite for the global cannabis industry to flourish, because the reliable testing of products is of paramount importance for; the well-being of patients and consumers, the success of businesses, the confidence of investors and the overall reputation of the industry.
Investors & analysts
Defensible sizing and forecasts to underwrite the thesis.
Corporate strategy & FMCG
Opportunity sizing and entry routes across key markets.